A recent study by European scientists shows that highly sensitive sensors based on color centers in a diamond can be used to record electrical activity
There may be a solid chunk of executives in the Endpoints 100 who feel that better times are ahead for the biotech industry in 2024,
Spyre Therapeutics is pulling in $180 million in a private placement just a couple of weeks after it rebranded from Aeglea BioTherapeutics. Spyre is selling
Kamau Therapeutics has emerged from stealth mode after inking a deal with Graphite Bio for its genome editing assets. Kamau’s debut comes less than a
Alexandra Glucksmann is always looking for “the next frontier” in medicine. After spending most of her career in genetic diseases, rare diseases and oncology, her
The FDA hasn’t recovered from its pause in foreign drug manufacturer inspections during the COVID-19 pandemic, with inspections in 2022 remaining “well below” pre-pandemic surveillance
SAN ANTONIO — Postmenopausal women with genomically low-risk early hormone receptor (HR)-positive breast cancer had a low risk of recurrence with endocrine therapy alone after
Women with pregnancy-related end-stage kidney disease (ESKD) had lower access to care compared with those who had other causes of ESKD, according to results from
Claire Panosian Dunavan is a professor of medicine and infectious diseases at the David Geffen School of Medicine at UCLA and a past-president of the
ChatGPT significantly outperformed humans on a mock version of the American Board of Psychiatry and Neurology (ABPN) boards. ChatGPT-4, the newer version of Open AI’s